Key result
Highly automatic-QT interval measurement (HA-QT) yielded placebo-baseline-adjusted QTc prolongations that were not significantly different from FDA-approved measurements (difference 1.4 ms, P=0.4).
Why the study?
Does a highly automatic-QT interval measurement (HA-QT) method accurately measure QTc prolongation compared to FDA-approved measurements in Thorough QT studies?
Does a highly automatic-QT interval measurement (HA-QT) method accurately measure QTc prolongation compared to FDA-approved measurements in Thorough QT studies?
Mean Difference: 1.4
p-value: p=0.4
A highly automated QT measurement method provides comparable results to FDA-approved measurements for assessing placebo-baseline-adjusted QTc prolongation in Thorough QT studies.
No takes yet. Share an insight, caveat, or question.
May support automated QTc assessment in Thorough QT studies; leaves open broader validation before routine use.
Couderc et al. (2011) studied this question. Highly automatic-QT interval measurement (HA-QT) vs. FDA-approved QTc measurement was evaluated on Placebo-baseline-adjusted QTc prolongation (MD 1.4, p=0.4). Highly automatic-QT interval measurement (HA-QT) yielded placebo-baseline-adjusted QTc prolongations that were not significantly different from FDA-approved measurements (difference 1.4 ms, P=0.4).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: